AZN icon

AstraZeneca

204.03 USD
-0.96
0.47%
At close Updated Apr 10, 4:00 PM EDT
Pre-market
After hours
204.03
0.00
0%
1 day
-0.47%
5 days
-0.35%
1 month
4.64%
3 months
117.91%
6 months
141.37%
Year to date
122.81%
1 year
214.52%
5 years
312.85%
10 years
601.38%
 

About: A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Employees: 96,100

0
Funds holding %
of 8,115 funds
Analysts bullish %
0
Positive news %
Price charts implemented using Lightweight Charts™